In Brief
Mocholi et al. show that, following T cell activation, activation of
autophagy constitutes a tolerance-avoidance mechanism that, through modulation
of cell metabolism and specific signaling pathways, allows T cells to engage in
effector responses and avoid anergy. In vivo inhibition of autophagy in T cells
induces tolerance and prevents autoimmunity.
In response to activation, CD4+ T cells upregulate autophagy.
However, the functional consequences of that upregulation have not been fully
elucidated. In this study, we identify autophagy as a tolerance-avoidance
mechanism. Our data show that inhibition of autophagy during CD4+ T
cell activation induces a long-lasting state of hypo-responsiveness that is
accompanied by the expression of an anergic gene signature. Cells unable to
induce autophagy after T cell receptor (TCR) engagement show inefficient
mitochondrial respiration and decreased turnover of the protein tyrosine
phosphatase PTPN1, which translates into defective TCR-mediated signaling.
In vivo, inhibition of autophagy during antigen priming
induces T cell anergy and decreases the severity of disease in an experimental
autoimmune encephalomyelitis mouse model. Interestingly, CD4+ T cells
isolated from the synovial fluid of juvenile idiopathic arthritis patients,
while resistant to suboptimal stimulation-induced anergy, can be tolerized with
autophagy inhibitors. We propose that autophagy constitutes a
tolerance-avoidance mechanism, which determines CD4+ T cell fate.